SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-005606
Filing Date
2019-02-04
Accepted
2019-02-04 18:35:45
Documents
1
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3877
  Complete submission text file 0001104659-19-005606.txt   5237
Mailing Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET, SUITE 1A CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS 325 VASSAR ST., STE. 1A CAMBRIDGE MA 02139
Business Address
OH ANDREW M. (Reporting) CIK: 0001746614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 19565640